866 related articles for article (PubMed ID: 15057233)
1. PPARs and the complex journey to obesity.
Evans RM; Barish GD; Wang YX
Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
[TBL] [Abstract][Full Text] [Related]
2. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
Andrééva-Gatéva P
Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
[TBL] [Abstract][Full Text] [Related]
3. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
4. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
Chinetti-Gbaguidi G; Fruchart JC; Staels B
Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
Spiegelman BM
Eur J Med Res; 1997 Nov; 2(11):457-64. PubMed ID: 9385114
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Rangwala SM; Lazar MA
Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
[TBL] [Abstract][Full Text] [Related]
7. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
Yumuk VD
Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
[TBL] [Abstract][Full Text] [Related]
8. The role of PPAR alpha in obesity.
Seedorf U; Assmann G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):189-94. PubMed ID: 11590995
[TBL] [Abstract][Full Text] [Related]
9. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
Uauy R; Martínez JI; Rojas CV
Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
Sridhar GR
J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
[TBL] [Abstract][Full Text] [Related]
11. [Peroxisome proliferator-activated receptors and atherosclerosis].
Jin N; Wang X
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
[TBL] [Abstract][Full Text] [Related]
12. PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval C; Fruchart JC; Staels B
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
Guan Y
J Am Soc Nephrol; 2004 Nov; 15(11):2801-15. PubMed ID: 15504933
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
Smith AG; Muscat GE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
[TBL] [Abstract][Full Text] [Related]
16. Evolution of peroxisome proliferator-activated receptor agonists.
Chang F; Jaber LA; Berlie HD; O'Connell MB
Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
[TBL] [Abstract][Full Text] [Related]
17. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
Moller DE; Berger JP
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma and metabolic disease.
Willson TM; Lambert MH; Kliewer SA
Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
[TBL] [Abstract][Full Text] [Related]
19. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
20. Focus issue: the signaling skinny on obesity.
Chong LD; Adler EM; Ray LB
Sci STKE; 2003 Feb; 2003(169):EG2. PubMed ID: 12582198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
